Literature DB >> 17964527

Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.

Janet Fawcett1, Paska A Permana, Jennifer L Levy, William C Duckworth.   

Abstract

Proteins are vital to the overall structure of cells and to the function of cells in the form of enzymes. Thus the control of protein metabolism is among the most important aspects of cellular metabolism. Insulin's major effect on protein metabolism in the adult animal is inhibition of protein degradation. This is via inhibition of proteasome activity via an interaction with insulin-degrading enzyme (IDE). IDE is responsible for the majority of cellular insulin degradation. We hypothesized that a reduction in IDE would reduce insulin degradation and insulin's ability to inhibit protein degradation. HepG2 cells were transfected with siRNA against human IDE and insulin degradation and protein degradation measured. Both IDE mRNA and protein were reduced by >50% in the IDE siRNA transfected cells. Insulin degradation was reduced by approximately 50%. Cells were labeled with [3H]-leucine to investigate protein degradation. Short-lived protein degradation was unchanged in the cells with reduced IDE expression. Long-lived and very-long-lived protein degradation was reduced in the cells with reduced IDE expression (14.0+/-0.16 vs. 12.5+/-0.07%/4h (long-lived), 9.6+/-2.2% vs. 7.3+/-0.2%/3h (very-long-lived), control vs. IDE transfected, respectively, P<0.005). The inhibition of protein degradation by insulin was reduced 37-76% by a decreased expression of IDE in HepG2 cells. This shows that IDE is involved in cellular insulin metabolism and provides further evidence that insulin inhibits protein degradation via an interaction with IDE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964527     DOI: 10.1016/j.abb.2007.09.019

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  13 in total

1.  Hyperglycaemia and hyperinsulinaemia: is insulin-degrading enzyme the missing link?

Authors:  J Fawcett; W C Duckworth
Journal:  Diabetologia       Date:  2009-06-06       Impact factor: 10.122

2.  Modulation of insulin degrading enzyme activity and liver cell proliferation.

Authors:  Olga Pivovarova; Christian von Loeffelholz; Iryna Ilkavets; Carsten Sticht; Sergei Zhuk; Veronica Murahovschi; Sonja Lukowski; Stephanie Döcke; Jennifer Kriebel; Tonia de las Heras Gala; Anna Malashicheva; Anna Kostareva; Johan F Lock; Martin Stockmann; Harald Grallert; Norbert Gretz; Steven Dooley; Andreas F H Pfeiffer; Natalia Rudovich
Journal:  Cell Cycle       Date:  2015-05-06       Impact factor: 4.534

3.  Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues.

Authors:  Christina Yfanti; Karin Mengele; Apostolos Gkazepis; Gregor Weirich; Cecylia Giersig; Wen-Liang Kuo; Wei-Jen Tang; Marsha Rosner; Manfred Schmitt
Journal:  Int J Mol Med       Date:  2008-10       Impact factor: 4.101

4.  Immunohistochemical evidence of ubiquitous distribution of the metalloendoprotease insulin-degrading enzyme (IDE; insulysin) in human non-malignant tissues and tumor cell lines.

Authors:  Gregor Weirich; Karin Mengele; Christina Yfanti; Apostolos Gkazepis; Daniela Hellmann; Anita Welk; Cecylia Giersig; Wen-Liang Kuo; Marsha Rich Rosner; Wei-Jen Tang; Manfred Schmitt
Journal:  Biol Chem       Date:  2008-11       Impact factor: 3.915

5.  Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells.

Authors:  O Pivovarova; O Gögebakan; A F H Pfeiffer; N Rudovich
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

6.  Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.

Authors:  Qing Guo; Marika Manolopoulou; Yao Bian; Alexander B Schilling; Wei-Jen Tang
Journal:  J Mol Biol       Date:  2009-11-05       Impact factor: 5.469

7.  Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis.

Authors:  Julie Charton; Marion Gauriot; Qing Guo; Nathalie Hennuyer; Xavier Marechal; Julie Dumont; Malika Hamdane; Virginie Pottiez; Valerie Landry; Olivier Sperandio; Marion Flipo; Luc Buee; Bart Staels; Florence Leroux; Wei-Jen Tang; Benoit Deprez; Rebecca Deprez-Poulain
Journal:  Eur J Med Chem       Date:  2014-04-04       Impact factor: 6.514

8.  Structural changes in intermediate filament networks alter the activity of insulin-degrading enzyme.

Authors:  Ying-Hao Chou; Wen-Liang Kuo; Marsha Rich Rosner; Wei-Jen Tang; Robert D Goldman
Journal:  FASEB J       Date:  2009-07-07       Impact factor: 5.191

9.  Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes.

Authors:  Natalia Rudovich; Olga Pivovarova; Eva Fisher; Antje Fischer-Rosinsky; Joachim Spranger; Matthias Möhlig; Matthias B Schulze; Heiner Boeing; Andreas F H Pfeiffer
Journal:  J Mol Med (Berl)       Date:  2009-10-07       Impact factor: 4.599

10.  Structure, function, and regulation of insulin-degrading enzyme.

Authors:  Raymond E Hulse; Luis A Ralat; Tang Wei-Jen
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.